Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 40INDUSTRY 22NETWORK 7NIH 3OTHER_GOV 2UNKNOWN 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 3Breast 2Sarcoma 1Plasma cell 1

Conditions

Breast Neoplasms 2Neoplasms by Site 1Neoplasms 1Fatigue 1Breast Diseases 1

Interventions

Tamoxifen 10Capecitabine 10Trastuzumab 9Docetaxel 9pyrotinib 7Exercise 7Control Groups 7Vinorelbine 6Paclitaxel 6Letrozole 6Gemcitabine 6Cyclophosphamide 6Carboplatin 6exemestane 5Indocyanine Green 5Anastrozole 5pertuzumab 4dalpiciclib 4Injections 4Fulvestrant 4Doxorubicin 4Surgical Procedures, Operative 3Standard of Care 3Radiotherapy 3Radiation 3Mammography 3Epirubicin 3Drug Therapy 3Cisplatin 3Bevacizumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Zoledronic Acid × Breast × Clear all
NCT04488614 2020-07-30

PBCB

Helse Stavanger HF

Enrolling by invitation
1,200 enrolled
Breast

Breast Neoplasms, Fatigue

NCT01472146 2017-05-09

ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer

Instituto Nacional de Cancer, Brazil

Phase 2 Completed
58 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon âš¡